Yahsou Delmas

8.4k total citations
78 papers, 3.0k citations indexed

About

Yahsou Delmas is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Yahsou Delmas has authored 78 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 39 papers in Nephrology and 24 papers in Hematology. Recurrent topics in Yahsou Delmas's work include Complement system in diseases (45 papers), Renal Diseases and Glomerulopathies (31 papers) and Adenosine and Purinergic Signaling (11 papers). Yahsou Delmas is often cited by papers focused on Complement system in diseases (45 papers), Renal Diseases and Glomerulopathies (31 papers) and Adenosine and Purinergic Signaling (11 papers). Yahsou Delmas collaborates with scholars based in France, United States and Italy. Yahsou Delmas's co-authors include Christian Combe, Véronique Frémeaux‐Bacchi, François Provôt, Chantal Loirat, Fádi Fakhouri, N. Grenier, Paul Coppo, Agnès Veyradier, Pierre Boisseau and Olivier Hauger and has published in prestigious journals such as Blood, PLoS ONE and Radiology.

In The Last Decade

Yahsou Delmas

76 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahsou Delmas France 27 1.8k 1.5k 778 664 418 78 3.0k
Spero R. Cataland United States 33 2.7k 1.5× 1.4k 0.9× 1.7k 2.2× 1.0k 1.6× 415 1.0× 113 3.7k
Paul Browne Ireland 26 1.5k 0.8× 678 0.5× 1.3k 1.7× 956 1.4× 858 2.1× 68 3.7k
Anita Hill United Kingdom 23 2.7k 1.5× 1.4k 0.9× 2.2k 2.8× 1.2k 1.8× 178 0.4× 54 4.2k
Han‐Mou Tsai United States 32 4.4k 2.4× 2.1k 1.4× 3.2k 4.1× 1.5k 2.3× 270 0.6× 72 5.6k
Kenneth H. Shumak Canada 16 1.9k 1.0× 978 0.7× 1.2k 1.5× 600 0.9× 149 0.4× 30 2.7k
Leticia Nolasco United States 25 2.2k 1.2× 707 0.5× 2.4k 3.1× 653 1.0× 248 0.6× 38 3.7k
Nicole A. Aqui United States 18 1.3k 0.7× 344 0.2× 862 1.1× 569 0.9× 295 0.7× 41 3.4k
Jack Bleesing United States 35 2.7k 1.5× 258 0.2× 1.8k 2.3× 379 0.6× 545 1.3× 108 4.0k
Hendrik B. Feys Belgium 25 988 0.5× 328 0.2× 1.2k 1.6× 489 0.7× 207 0.5× 73 2.2k
Kenneth D. Friedman United States 33 894 0.5× 379 0.3× 2.0k 2.5× 514 0.8× 159 0.4× 98 3.0k

Countries citing papers authored by Yahsou Delmas

Since Specialization
Citations

This map shows the geographic impact of Yahsou Delmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahsou Delmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahsou Delmas more than expected).

Fields of papers citing papers by Yahsou Delmas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahsou Delmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahsou Delmas. The network helps show where Yahsou Delmas may publish in the future.

Co-authorship network of co-authors of Yahsou Delmas

This figure shows the co-authorship network connecting the top 25 collaborators of Yahsou Delmas. A scholar is included among the top collaborators of Yahsou Delmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahsou Delmas. Yahsou Delmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joly, Bérangère S., Adrien Joseph, Pierre Boisseau, et al.. (2025). Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura. Blood Advances. 10(5). 1831–1842.
2.
Fakhouri, Fádi, Yahsou Delmas, Sophie Caillard, et al.. (2024). Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome. American Journal of Kidney Diseases. 84(2). 244–249. 3 indexed citations
3.
Coppo, Paul, Vassilis Tsatsaris, Pierre Boisseau, et al.. (2023). Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience. Blood Advances. 8(1). 183–193. 7 indexed citations
4.
Burguet, Laure, Benjamin Taton, Sébastien Rubin, et al.. (2022). Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis. Journal of Clinical Medicine. 11(3). 648–648. 6 indexed citations
5.
Précigout, V. de, Yahsou Delmas, Véronique Dubois, et al.. (2022). Performance of real-time PCR in suspected haemodialysis catheter-related bloodstream infection: a proof-of-concept study. Clinical Kidney Journal. 16(3). 494–500. 2 indexed citations
6.
Joseph, Adrien, Benoît Brilland, Laure Burguet, et al.. (2022). Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?. Kidney International Reports. 7(11). 2541–2542. 1 indexed citations
7.
Simon‐Tillaux, Noémie, François Provôt, Yahsou Delmas, et al.. (2019). Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors. Kidney International. 95(6). 1443–1452. 69 indexed citations
8.
Walle, Johan Vande, Yahsou Delmas, Gianluigi Ardissino, et al.. (2016). Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment. Journal of Nephrology. 30(1). 127–134. 79 indexed citations
10.
Imasawa, Toshiyuki, Toshiyuki Imasawa, Émilie Obre, et al.. (2016). High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy. The FASEB Journal. 31(1). 294–307. 85 indexed citations
11.
Servais, Aude, Véronique Frémeaux‐Bacchi, Aurélie Hummel, et al.. (2016). Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab. Nephrology Dialysis Transplantation. 31(12). 2122–2130. 65 indexed citations
12.
Fakhouri, Fádi, Marc Fila, François Provôt, et al.. (2016). Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation. Clinical Journal of the American Society of Nephrology. 12(1). 50–59. 126 indexed citations
13.
Licht, Christoph, Larry A. Greenbaum, Petra Muus, et al.. (2015). Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies. Kidney International. 87(5). 1061–1073. 296 indexed citations
14.
Rivière, Étienne, Chloé James, Yahsou Delmas, et al.. (2015). Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count. Transfusion. 55(7). 1798–1802. 19 indexed citations
15.
Delmas, Yahsou, et al.. (2013). Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice. Clinical Kidney Journal. 6(2). 243–244. 25 indexed citations
16.
Derieppe, Marc, Yahsou Delmas, Jean‐Luc Gennisson, et al.. (2011). Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats. European Radiology. 22(1). 243–250. 45 indexed citations
17.
Stojanovic, Katia Stankovic, Yahsou Delmas, Julie Peltier, et al.. (2011). Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure. Nephrology Dialysis Transplantation. 27(5). 1898–1901. 91 indexed citations
18.
Grenier, N., Olivier Hauger, Yahsou Delmas, & Christian Combe. (2006). MR imaging of nephropathies. Abdominal Imaging. 31(2). 213–223. 8 indexed citations
19.
Bos, Clemens, Yahsou Delmas, Alexis Desmoulière, et al.. (2004). In Vivo MR Imaging of Intravascularly Injected Magnetically Labeled Mesenchymal Stem Cells in Rat Kidney and Liver. Radiology. 233(3). 781–789. 189 indexed citations
20.
Dubus, Isabelle, et al.. (2002). Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney International. 62(3). 857–867. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026